Cancer researchers have discovered something remarkable hiding in plain sight: a common bacteria used to make sauerkraut and ...

Pancreatic cancer continues to pose one of the greatest challenges in global cancer treatment. Known for its aggressive ...

Background Steatotic liver disease-related hepatocellular carcinoma (SLD-HCC), a rising global challenge, is characterised by ...

New RNA vaccine shows promise in turning resistant tumors into immunotherapy targets. Study offers hope for more effective, ...

Researchers at MUSC Hollings Cancer Center have identified a signaling loop involved in the growth and persistence of ...

Allogeneic cell therapies are advancing in clinical trials, requiring oncologists and pathologists to understand the ...

A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune ...

Market OutlineThe Global Single Cell Analysis Market is valued at USD 4.90 Billion in 2024 and is projected to attain a value ...

In this article, you’ll find some of the top content that was published on LCGC this week, including details on the recent merger between Waters Corporation and BD Biosciences.

The global companion diagnostics market is set to surge from USD 7.03 Billion in 2024 to USD 22.83 Billion by 2034, driven by rising cancer prevalenc ...

A team used generative AI to enhance T cells’ ability to fight melanoma. The immunotherapy approach needs more testing before use in cancer patients.

Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to new research from ...